Real patient results — melasma, sunspots, and post-inflammatory marks visibly reduced
Before
After






Hyperpigmentation occurs when melanocytes produce excess melanin in localized areas. The most common forms include melasma (hormonally triggered, often symmetric patches on cheeks, forehead, or upper lip), sunspots or solar lentigines (UV-induced flat brown spots on sun-exposed areas), and post-inflammatory hyperpigmentation (dark marks left after acne, injury, or irritation). In all cases, the excess pigment is concentrated primarily in the upper epidermis — making controlled epidermal renewal a direct and effective approach.
The treatment works through controlled epidermal renewal combined with collagen stimulation. Derma plasma (80–140°C) is applied across larger affected areas, producing a homogeneous thermal effect that accelerates the natural shedding of the pigment-loaded epidermal layer. For smaller, pinpoint spots or stubborn melasma patches, the warm plasma silver needle tip (120–400°C) delivers targeted energy directly into the pigmented zone. As the micro-injured epidermis renews itself, the excess melanin is carried away with the shedding cells. Simultaneously, the controlled thermal stimulus triggers fibroblast activation and new collagen formation, improving both skin texture and tone uniformity. Hyper plasma closes every session — sterilizing the area, calming inflammation, and shortening recovery time.
Sun protection is the most critical factor in maintaining results — unprotected skin is vulnerable to spot recurrence and even darkening. SPF 30+ is mandatory daily for at least 2–3 weeks post-treatment. In Fitzpatrick V–VI (darker) skin types, the procedure must be performed at lower energy levels; the risk of post-inflammatory hyperpigmentation remains higher in these skin types and must be discussed with the patient beforehand.
Our expert team has prepared a specialized protocol for Spots & Hyperpigmentation treatment.
Demo & ConsultationGet Protocol Training
This treatment is performed using a clinically developed protocol with the Cold Plasma and Warm Plasma technologies of the Fusion Plasma Pro device.